First Time Loading...
M

Middle East Pharmaceutical Industries Company SJSC
SAU:4016

Watchlist Manager
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Watchlist
Price: 147.6 SAR 1.79% Market Closed
Updated: May 5, 2024

Wall Street
Price Targets

Price Targets Summary
Middle East Pharmaceutical Industries Company SJSC

Wall Street analysts forecast Middle East Pharmaceutical Industries Company SJSC stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Middle East Pharmaceutical Industries Company SJSC is 109.14 SAR with a low forecast of 108.07 SAR and a high forecast of 112.35 SAR.

Lowest
Price Target
108.07 SAR
27% Downside
Average
Price Target
109.14 SAR
26% Downside
Highest
Price Target
112.35 SAR
24% Downside
Middle East Pharmaceutical Industries Company SJSC Competitors:
Price Targets
4536
Santen Pharmaceutical Co Ltd
15% Upside
CAPLIPOINT
Caplin Point Laboratories Ltd
25% Upside
688526
Wuhan Keqian Biology Co Ltd
50% Upside
4578
Otsuka Holdings Co Ltd
1% Downside
4516
Nippon Shinyaku Co Ltd
59% Upside
ARVN
Arvinas Inc
117% Upside
GRANULES
Granules India Ltd
7% Upside
TSPC
Tempo Scan Pacific Tbk PT
14% Downside

Revenue
Forecast

Revenue Estimate
Middle East Pharmaceutical Industries Company SJSC

For the last 1 year the compound annual growth rate for Middle East Pharmaceutical Industries Company SJSC's revenue is 5%. The projected CAGR for the next 4 years is 14%.

5%
Past Growth
14%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Middle East Pharmaceutical Industries Company SJSC

For the last 1 year the compound annual growth rate for Middle East Pharmaceutical Industries Company SJSC's operating income is -2%. The projected CAGR for the next 4 years is 15%.

-2%
Past Growth
15%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Middle East Pharmaceutical Industries Company SJSC

For the last 1 year the compound annual growth rate for Middle East Pharmaceutical Industries Company SJSC's net income is -10%. The projected CAGR for the next 4 years is 15%.

-10%
Past Growth
15%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Middle East Pharmaceutical Industries Company SJSC's stock price target?
Price Target
109.14 SAR

According to Wall Street analysts, the average 1-year price target for Middle East Pharmaceutical Industries Company SJSC is 109.14 SAR with a low forecast of 108.07 SAR and a high forecast of 112.35 SAR.

What is Middle East Pharmaceutical Industries Company SJSC's Revenue forecast?
Projected CAGR
14%

For the last 1 year the compound annual growth rate for Middle East Pharmaceutical Industries Company SJSC's revenue is 5%. The projected CAGR for the next 4 years is 14%.

What is Middle East Pharmaceutical Industries Company SJSC's Operating Income forecast?
Projected CAGR
15%

For the last 1 year the compound annual growth rate for Middle East Pharmaceutical Industries Company SJSC's operating income is -2%. The projected CAGR for the next 4 years is 15%.

What is Middle East Pharmaceutical Industries Company SJSC's Net Income forecast?
Projected CAGR
15%

For the last 1 year the compound annual growth rate for Middle East Pharmaceutical Industries Company SJSC's net income is -10%. The projected CAGR for the next 4 years is 15%.